These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1052676)

  • 1. Analogs of somatostatin. Part B. In vivo activities: prolongation of action with protamine zinc.
    Brazeau P; Martin JB
    Curr Top Mol Endocrinol; 1976; 3():379-86. PubMed ID: 1052676
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 3. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat.
    Ferland L; Labrie F; Coy DH; Arimura A; Schally AV
    Mol Cell Endocrinol; 1976 Jan; 4(2):79-88. PubMed ID: 1248667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffectiveness of protamine zinc somatostatin as a long-acting inhibitor of insulin and growth hormone secretion.
    Tannenbaum GS; Colle E
    Can J Physiol Pharmacol; 1980 Aug; 58(8):951-5. PubMed ID: 6112055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic and immunologic activities and applications of somatostatin analogs.
    Vale W; Rivier J; Ling N; Brown M
    Metabolism; 1978 Sep; 27(9 Suppl 1):1391-401. PubMed ID: 210361
    [No Abstract]   [Full Text] [Related]  

  • 9. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vivo assay of antisomatotropic activity of somatostatin and two of its analogs].
    Franchimont P; Ghys A; Brison J; Haze-Hagelstein MT; Detournay JM; Dremier C; Scarso A; Demoulin A; Dirkx J
    C R Seances Soc Biol Fil; 1977; 171(3):673-8. PubMed ID: 144010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications.
    Janecka A; Zubrzycka M
    Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 15. Analogs of somatostatin. Part A. Chemistry and in vitro results.
    Immer H; Abraham NA; Nelson V; Sestanj K; Götz M; Brazeau P; Martin JB
    Curr Top Mol Endocrinol; 1976; 3():373-8. PubMed ID: 1052675
    [No Abstract]   [Full Text] [Related]  

  • 16. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.
    Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH
    Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-opiate binding and morphine antagonism by octapeptide analogs of somatostatin.
    Walker JM; Bowen WD; Atkins ST; Hemstreet MK; Coy DH
    Peptides; 1987; 8(5):869-75. PubMed ID: 2893361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally restricted bicyclic analogs of somatostatin.
    Veber DF; Holly FW; Paleveda WJ; Nutt RF; Bergstrand SJ; Torchiana M; Glitzer MS; Saperstein R; Hirschmann R
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2636-40. PubMed ID: 208068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
    Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
    Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
    [No Abstract]   [Full Text] [Related]  

  • 20. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.